[go: up one dir, main page]

MX2014003015A - Biosensor con compensacion de error. - Google Patents

Biosensor con compensacion de error.

Info

Publication number
MX2014003015A
MX2014003015A MX2014003015A MX2014003015A MX2014003015A MX 2014003015 A MX2014003015 A MX 2014003015A MX 2014003015 A MX2014003015 A MX 2014003015A MX 2014003015 A MX2014003015 A MX 2014003015A MX 2014003015 A MX2014003015 A MX 2014003015A
Authority
MX
Mexico
Prior art keywords
function
residual
primary
ssp
error
Prior art date
Application number
MX2014003015A
Other languages
English (en)
Other versions
MX350696B (es
Inventor
Huan-Ping Wu
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of MX2014003015A publication Critical patent/MX2014003015A/es
Publication of MX350696B publication Critical patent/MX350696B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Electrochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

Un sistema biosensor determina la concentración de un analito a partir de una señal de salida que es generada a partir de una especie identificable con luz o una reacción de redox del analito. Este biosensor puede determinar por ejemplo la concentración de glucosa en sangre. El sistema biosensor compensa por lo menos 50% del error total en la señal de salida con una función primaria y puede compensar una porción del error residual con por lo menos una función residual. Una función basada en el procesamiento de señales segmentadas (SSP) puede servir como la función primaria, la primera función residual o la segunda función residual. Preferiblemente, cuando la función de SSP sirve como la primera función residual, la función de SSP compensa por lo menos 50% del error residual que permanece después de la compensación primaria. Preferiblemente, cuando la función de SSP sirve como la segunda función residual, la función de SSP compensa por lo menos 50% del error residual que permanece después de la compensación primaria y la primera compensación residual. La compensación de error proporcionada por la función primaria, la primera función residual y la segunda función residual se puede ajustar con coeficientes de ponderación de funciones. La figura más representativa de la invención es la número 1A.
MX2014003015A 2011-09-21 2012-09-20 Biosensor con compensación de error. MX350696B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161537145P 2011-09-21 2011-09-21
PCT/US2012/056280 WO2013043839A1 (en) 2011-09-21 2012-09-20 Biosensor with error compensation

Publications (2)

Publication Number Publication Date
MX2014003015A true MX2014003015A (es) 2014-05-07
MX350696B MX350696B (es) 2017-09-14

Family

ID=47881000

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003015A MX350696B (es) 2011-09-21 2012-09-20 Biosensor con compensación de error.

Country Status (8)

Country Link
US (2) US9775806B2 (es)
EP (3) EP2758039B1 (es)
JP (1) JP6082396B2 (es)
KR (1) KR20140063829A (es)
ES (2) ES2757909T3 (es)
MX (1) MX350696B (es)
TW (1) TWI600892B (es)
WO (1) WO2013043839A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368104B (es) * 2010-03-22 2019-09-19 Ascensia Diabetes Care Holdings Ag Compensacion residual para un biosensor.
JP6280203B2 (ja) 2013-03-14 2018-02-14 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ 分析物濃度決定のシステム誤差補償
CN105378484B (zh) 2013-03-14 2017-06-09 安晟信医疗科技控股公司 分析物浓度测定的标准化校准
ES2715407T3 (es) 2013-03-14 2019-06-04 Ascensia Diabetes Care Holdings Ag Aproximación progresiva de la concentración de un analito de muestra
US10551362B2 (en) 2013-03-26 2020-02-04 Waters Technologies Corporation Method for extending the dynamic range of absorbance detectors
GB2531728A (en) 2014-10-27 2016-05-04 Cilag Gmbh Int Method for determining diffusion
HK1248818A1 (zh) 2015-05-15 2018-10-19 安晟信医疗科技控股公司 改进的生物传感器系统分析物测量
CN109690304A (zh) * 2016-07-12 2019-04-26 安晟信医疗科技控股公司 通过使用来自两个电极的交替输出信号进行电化学分析的方法
CA3045090A1 (en) * 2016-12-05 2018-06-14 Ascensia Diabetes Care Holdings Ag Risk factor monitoring
EP3887814A4 (en) * 2018-12-02 2022-08-24 Polymer Technology Systems, Inc. SYSTEMS AND METHODS FOR AN ELECTRONIC GRID CHARACTERISTIC IN AN ELECTROCHEMICAL TEST STRIP
WO2020161099A1 (en) 2019-02-05 2020-08-13 Ascensia Diabetes Care Holdings Ag Apparatus and methods for probing sensor operation of continuous analyte sensing and auto-calibration
JP2022521409A (ja) 2019-02-22 2022-04-07 アセンシア・ディアベティス・ケア・ホールディングス・アーゲー 高調波関係を使用した分析対象物濃度モニタリングの方法および装置
CN109884150B (zh) * 2019-03-08 2021-05-14 武汉璟泓科技股份有限公司 一种红细胞积压校正方法及存储介质
US11678820B2 (en) 2019-09-10 2023-06-20 Ascensia Diabetes Care Holdings Ag Methods and apparatus for information gathering, error detection and analyte concentration determination during continuous analyte sensing
CN112432988B (zh) * 2020-11-25 2023-03-03 重庆迈联医疗科技有限公司 电化学测试系统的温度校正方法
CN114777888B (zh) * 2022-04-28 2024-09-20 四川泛华航空仪表电器有限公司 一种基于光纤光栅压力传感器液位测量误差补偿修正方法
CN119224239B (zh) * 2024-12-02 2025-04-18 无锡零界净化设备股份有限公司 一种用于离线式浓度监测仪的信号增强方法及平台

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431004A (en) 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4750496A (en) 1987-01-28 1988-06-14 Xienta, Inc. Method and apparatus for measuring blood glucose concentration
US5243516A (en) 1989-12-15 1993-09-07 Boehringer Mannheim Corporation Biosensing instrument and method
US5508171A (en) 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
FR2701117B1 (fr) 1993-02-04 1995-03-10 Asulab Sa Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose.
US5366609A (en) 1993-06-08 1994-11-22 Boehringer Mannheim Corporation Biosensing meter with pluggable memory key
US5352351A (en) 1993-06-08 1994-10-04 Boehringer Mannheim Corporation Biosensing meter with fail/safe procedures to prevent erroneous indications
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US6153069A (en) 1995-02-09 2000-11-28 Tall Oak Ventures Apparatus for amperometric Diagnostic analysis
US5582697A (en) 1995-03-17 1996-12-10 Matsushita Electric Industrial Co., Ltd. Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
US5620579A (en) * 1995-05-05 1997-04-15 Bayer Corporation Apparatus for reduction of bias in amperometric sensors
US5723284A (en) 1996-04-01 1998-03-03 Bayer Corporation Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood
DE69809391T2 (de) 1997-02-06 2003-07-10 Therasense, Inc. Kleinvolumiger sensor zur in-vitro bestimmung
US6391558B1 (en) 1997-03-18 2002-05-21 Andcare, Inc. Electrochemical detection of nucleic acid sequences
US6391645B1 (en) 1997-05-12 2002-05-21 Bayer Corporation Method and apparatus for correcting ambient temperature effect in biosensors
US5798031A (en) 1997-05-12 1998-08-25 Bayer Corporation Electrochemical biosensor
EP0990151A2 (en) 1997-06-16 2000-04-05 ELAN CORPORATION, Plc Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods
HU222809B1 (hu) 1997-10-03 2003-10-28 77 Elektronika Műszeripari Kft. Eljárás és készülék kémiai összetevőnek anyagmintából, különösen vér glükóztartalmának vérmintából történő meghatározásához
US7494816B2 (en) * 1997-12-22 2009-02-24 Roche Diagnostic Operations, Inc. System and method for determining a temperature during analyte measurement
CN1183384C (zh) 1997-12-22 2005-01-05 罗赫诊断器材公司 测量仪
ATE258028T1 (de) 1998-05-13 2004-02-15 Cygnus Therapeutic Systems Signalverarbeitung zur messung von physiologischen analyten
JP4256588B2 (ja) 1998-05-20 2009-04-22 アークレイ株式会社 統計的手法を用いた電気化学的測定方法および測定装置
US6475372B1 (en) 2000-02-02 2002-11-05 Lifescan, Inc. Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
CA2305922C (en) 1999-08-02 2005-09-20 Bayer Corporation Improved electrochemical sensor design
AU7590300A (en) 1999-09-20 2001-04-24 Roche Diagnostics Corporation Small volume biosensor for continuous analyte monitoring
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
JP4050434B2 (ja) 1999-11-29 2008-02-20 松下電器産業株式会社 サンプルの弁別方法
CN102012389B (zh) 2001-01-17 2013-04-10 爱科来株式会社 使用传感器的定量分析方法和定量分析装置
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
US6541266B2 (en) 2001-02-28 2003-04-01 Home Diagnostics, Inc. Method for determining concentration of an analyte in a test strip
AU784254B2 (en) 2001-05-21 2006-03-02 Bayer Corporation Improved electrochemical sensor
US6982178B2 (en) 2002-06-10 2006-01-03 E Ink Corporation Components and methods for use in electro-optic displays
US6797150B2 (en) 2001-10-10 2004-09-28 Lifescan, Inc. Determination of sample volume adequacy in biosensor devices
WO2003034055A1 (en) 2001-10-12 2003-04-24 Arkray, Inc. Concentration measuring method and concentration measuring device
CA2419213C (en) 2002-03-07 2011-06-21 Bayer Healthcare Llc Improved electrical sensor
US6946299B2 (en) 2002-04-25 2005-09-20 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US6964871B2 (en) 2002-04-25 2005-11-15 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
AU2003234944A1 (en) 2002-08-27 2004-03-18 Bayer Healthcare, Llc Methods of Determining Glucose Concentration in Whole Blood Samples
US7132041B2 (en) 2003-02-11 2006-11-07 Bayer Healthcare Llc Methods of determining the concentration of an analyte in a fluid test sample
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
CA2535833C (en) 2003-08-21 2013-11-26 Agamatrix, Inc. Method and apparatus for assay of electrochemical properties
JP4449431B2 (ja) 2003-11-19 2010-04-14 パナソニック株式会社 基質濃度の測定方法
US7862695B2 (en) 2004-02-06 2011-01-04 Bayer Healthcare, Llc Electrochemical biosensor
CA2559297C (en) 2004-04-19 2012-05-22 Matsushita Electric Industrial Co., Ltd. Method for measuring blood components and biosensor and measuring instrument for use therein
TW200608019A (en) 2004-05-14 2006-03-01 Bayer Healthcare Llc Methods for performing hematocrit adjustment in glucose assays and devices for same
CA2583396C (en) 2004-10-12 2015-06-23 Bayer Healthcare Llc Concentration determination in a diffusion barrier layer
GB0428547D0 (en) 2004-12-31 2005-02-09 Euroflow Uk Ltd Methods and apparatus for observing vessel contents
GB0501826D0 (en) 2005-01-28 2005-03-09 Melys Diagnostics Ltd Apparatus for measurement of analyte concentration
BRPI0609633B1 (pt) 2005-04-08 2016-01-26 Bayer Healthcare Llc espécies oxidáveis como uma referência interna em soluções de controle para biossensores
US7517439B2 (en) 2005-04-15 2009-04-14 Agamatrix, Inc. Error detection in analyte measurements based on measurement of system resistance
EP1913374B1 (en) 2005-07-20 2019-01-09 Ascensia Diabetes Care Holdings AG Method for signalling the user to add additional sample to a test strip, method for measuring the temperature of a sample and methods for determining the concentration of an analyte based on gated amperometry
CA2623480C (en) 2005-09-30 2015-05-05 Bayer Healthcare Llc Gated voltammetry
EP2572632B1 (en) * 2006-02-27 2020-02-19 Ascensia Diabetes Care Holdings AG Temperature-adjusted analyte determination for biosensor systems
US7966859B2 (en) 2006-05-03 2011-06-28 Bayer Healthcare Llc Underfill detection system for a biosensor
TWI431273B (zh) 2006-05-08 2014-03-21 Bayer Healthcare Llc 生物感測器用之異常輸出偵測系統
CA2656952C (en) * 2006-07-05 2014-09-23 Panasonic Corporation Liquid sample measurement method and apparatus
US20080248581A1 (en) 2007-04-06 2008-10-09 Bayer Healthcare Llc Method for performing correction of blood glucose assay bias using blood hemoglobin concentration
US8101062B2 (en) 2007-07-26 2012-01-24 Nipro Diagnostics, Inc. System and methods for determination of analyte concentration using time resolved amperometry
BRPI0814201A2 (pt) 2007-07-26 2015-01-27 Home Diagnostics Inc Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador
CN103760356B (zh) * 2007-12-10 2019-06-28 安晟信医疗科技控股公司 斜率式补偿
BRPI0923342A2 (pt) 2008-12-08 2016-01-12 Bayer Healthcare Llc sistema biosensor com ajuste de sinal
JP5782044B2 (ja) 2009-11-10 2015-09-24 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅＬＬＣ バイオセンサ用の充填量不足認識システム
JP5856154B2 (ja) 2010-06-07 2016-02-09 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅＬＬＣ 二次出力シグナルを含む勾配に基づく補正

Also Published As

Publication number Publication date
US20170360712A1 (en) 2017-12-21
EP2758039A1 (en) 2014-07-30
EP3586831A1 (en) 2020-01-01
EP2758039B1 (en) 2018-01-24
TW201314195A (zh) 2013-04-01
JP2014527186A (ja) 2014-10-09
EP3315123B1 (en) 2019-08-21
KR20140063829A (ko) 2014-05-27
US9775806B2 (en) 2017-10-03
ES2663097T3 (es) 2018-04-11
JP6082396B2 (ja) 2017-02-15
US20130071869A1 (en) 2013-03-21
TWI600892B (zh) 2017-10-01
ES2757909T3 (es) 2020-04-30
MX350696B (es) 2017-09-14
EP3315123A1 (en) 2018-05-02
WO2013043839A1 (en) 2013-03-28
US10646445B2 (en) 2020-05-12

Similar Documents

Publication Publication Date Title
MX2014003015A (es) Biosensor con compensacion de error.
MX368104B (es) Compensacion residual para un biosensor.
MX369764B (es) Compensación basada en la pendiente que incluye señales de salida secundarias.
WO2011119201A3 (en) Calibration of glucose monitoring sensor and/or insulin delivery system
EP2600524A3 (en) Adaptive crosstalk rejection
EP4360541A3 (en) Determining end of life of continuous analyte sensors
DE602006003615D1 (de) Glukosebiosensor und Verfahren
WO2010062627A3 (en) Biosensors based on optical probing and sensing
MX367439B (es) Sistema de gestion de llenado insuficiente para un biosensor.
WO2009019655A3 (en) Method and apparatus for discriminating modulated light in a mixed light system
WO2013078426A3 (en) Analyte monitoring system and methods of use
EP3955004A3 (en) Use of fatty acids in methods for detecting cancer
WO2019164402A8 (en) Bioluminescent biosensor for detecting and quantifying biomolecules
EP4231309A3 (en) Systems and methods for managing glycemic variability
WO2009031045A3 (en) Anti-chikungunya monoclonal antibodies and uses thereof
WO2008060694A3 (en) System and/or method for determining sufficiency of pseudorange measurements
WO2007089665A3 (en) Storage-stable cellular whole blood composition containing elevated amounts of d-dimer
EP4541272A3 (en) Methods of lag-compensation for analyte measurements, and devices related thereto
WO2009060825A1 (ja) 血中成分の濃度を精度よく測定する装置および方法
Watanabe et al. Antioxidant Properties of Albumin and Diseases Related to Obstetrics and Gynecology
GB201113435D0 (en) Sensor calibration
WO2008059041A3 (en) Complementation of factor xi deficiency by factor v mutants
WO2007146702A3 (en) Method for detecting il-16 activity and modulation of il-16 activity based on rantes proxy levels
MX2012013890A (es) Bateria geneticamente modificada de la especie listeria monocytogenes.
TW200746347A (en) Stage apparatus

Legal Events

Date Code Title Description
GB Transfer or assignment

Owner name: ASCENSIA DIABETES CARE HOLDINGS AG

FG Grant or registration